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Novel approaches to cancer gene therapy currently exploit tumour hypoxia to achieve transcriptional targeting using oxygen-
regulated enhancer elements called hypoxia response elements. The activity of such elements in hypoxic cells is directly
dependent on upregulation of the hypoxia-inducible transcription factor-1 However tumours also contain areas of anoxia,
which may be considered a more tumour-selective transcriptional stimulus than hypoxia for targeting gene therapy to
tumours. Another element, from the rat virus-like retrotransposon, VL30 (termed the ‘secondary anoxia response element’)
has been reported to be more highly inducible in rat fibroblasts under anoxia than hypoxia. To investigate anoxia as a
potential transcriptional target in human tumours, we have examined secondary anoxia response element inducibility in two
human breast cancer cell lines, MCF-7 and T47D, under anoxia, hypoxia and normoxia. In both cell types, the trimerised
secondary anoxia response element showed greater inducibility in anoxia than hypoxia (1% and 0.5% O2). The anoxic
response of the secondary anoxia response element was shown to be dependent on hypoxia-inducible transcription factor-1
and the presence of a hypoxia-inducible transcription binding site consensus (5’-ACGTG-3’). Mutational analysis demonstrated
that the base immediately 5’ to this modulates the anoxic/hypoxic induction of the secondary anoxia response element, such
that TACGTG4GACGTG44CACGTG. A similar correlation was found for erythropoietin, phosphoglycerate kinase 1, and
aldolase hypoxia response elements, which contain these respective 5’ flanking bases.
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Multiple areas of hypoxia and anoxia (i.e. pO2 0 – 23 mmHg or 0 –
3% O2) exist in malignant tumours (Vaupel et al, 1989). Hypoxia
induces various transcription factors, including hypoxia-inducible
factors (HIFs) 1 and 2 (Wang and Semenza, 1995; Tian et al,
1997). These heterodimers consist of a and b subunits, the former
being rapidly degraded by the ubiquitin-proteasome system in
normoxia (Salceda and Caro, 1997) but not hypoxia. HIF-1 trans-
activates gene expression in hypoxia by binding to cognate DNA
binding sites (consensus sequence 5’-RCGTG-3’) in hypoxia
response elements (HREs) present in promoters of corresponding
genes (Semenza et al, 1996). The HIF-1/HRE system is currently
being exploited to achieve hypoxic transcriptional targeting in
anti-cancer gene therapies (Dachs et al, 1997; Ido et al, 2001).
However tumours also contain anoxic areas (Vaupel et al, 1989),
and as some normal tissues also contain mildly hypoxic areas,
tumour anoxia could be used as a more specific tumour targeting
parameter for gene therapy than hypoxia.
In order to investigate anoxia as a potential target in gene ther-
apy we have examined the activity of an element derived from the
rat VL30 element, in two human cancer cell lines. VL30 elements
are a multigene family and members of the class of retroviruses
and retrovirus-like transposable elements (retroposons or retro-
transposons) present in normal rat and mouse DNA (Anderson
and Stoler, 1993). Examination of normal rat tissues has demon-
strated very low levels of VL30 expression, whereas high levels
have been found in rat malignancies, and rat fibroblasts exposed
to anoxia (Anderson et al, 1989). Induction of the rat VL30
element RNA is markedly different in anoxia vs hypoxia, with
the former stimulating induction up to 500-fold and hypoxic
conditions (0.1 – 2% O2) only a giving a 10-fold induction (Ander-
son et al, 1989).
A 14 base-pair sequence has been shown to mediate the anoxic
response of the rat VL30. This sequence demonstrated a greater
response in anoxia than in hypoxia (1% O2) in primary rat fibro-
blasts and was therefore termed a ‘secondary anoxia responsive
element’ (SARE) (Estes et al, 1995). Furthermore, a factor termed
the ‘anoxia inducible factor’ (AIF) was shown to be specifically
induced in rat fibroblasts under anoxia (Estes et al, 1995). This
factor was shown to bind to the SARE more predominantly than
HIF-1 in anoxia and thus it was suggested that the anoxic response
of the SARE was mediated by AIF. However, the anoxic inducibil-
ity of the SARE in human cells has not been investigated to date.
Here, we have examined the activity of the SARE in anoxic,
hypoxic and normoxic conditions in two human breast cancer cell
lines, and compared its inducibility to that of three well-charac-
terised HREs from promoters of the human erythropoietin
(EPO), human aldolase (ALD) and murine phosphoglycerate
kinase 1 (PGK-1) genes. Since the SARE also contains a HIF-1-
binding site (HBS), we used point-mutational analysis, electro-
phoretic mobility super-shift assays (EMSAs) and a HIF-1a
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deficient CHO cell line to investigate the importance of HIF-1, the
HIF-1 binding site consensus (HBS), and the base immediately 5’
to this, in the anoxic and hypoxic inducibility of the SARE in
human cancer cells.
MATERIALS AND METHODS
Cell line and culture conditions
MCF-7 cells were obtained from the European collection of cell
cultures (ECACC) and maintained in DMEM supplemented with
10% (v v71) foetal calf serum, penicillin (100 U ml71), streptomy-
cin (100 mg ml71), Fungizone (1.25 mg ml71), 4 mM L-glutamine
(Gibco), and insulin (2 U ml71) (Human Actrapid, Novo
Nordisk). T47D cells were obtained from ECACC and maintained
in the same media used for MCF-7 cells, but without addition of
insulin. HIF-1a positive and negative Chinese hamster ovary cells
were provided by Professor Peter Ratcliffe, Oxford, and maintained
as described previously (Wood et al, 1998).
Plasmid construction
Previous reports have demonstrated that multimerising HREs
amplifies their response to hypoxia (Firth et al, 1994). Thus, for
analytical purposes, we have investigated the ability of a SARE
trimer to regulate reporter (luciferase; LUC) gene expression in
the human breast cancer cell lines, MCF-7 and T47D, in normoxia
(21% O2), ‘physiological’ hypoxia (4% O2), pathological levels of
hypoxia (0.5 – 1% O2) and anoxia. We noted that the antisense
strand of the SARE contains a HBS (see Table 1a), and therefore
investigated the relative contributions of this and the putative
‘anoxia-responsive’ 5’-ACGTA-3’ site (Estes et al, 1995) to the
anoxic and hypoxic inducibility of the SARE, by making three
single-base pair SARE mutants in trimerised form (mutants M1-
3: see Table 1a). M1 was mutated to replace the putative anoxia-
responsive sequence 5’-CACGTA-3’ with a HBS 5’-CACGTg-3’ in
the upper strand, and also resulted in a change in the antisense
HBS from 5’-TACGTG-3’ to 5’-CACGTG-3’. In M2, the antisense
HBS was mutated to 3’ – TACGTa-5’, so that the HBS, 5’-
ACGTG-3’, was lost and the putative anoxia response sequence,
5’-ACGTA-3’, was present on both strands. In M3, the putative
anoxia-responsive sequence, 5’-CACGTA-3’, on the sense strand
was changed to 5’-CACGTc-3’, resulting in a change in the anti-
sense strand HBS from 5’-TACGTG-3’ to 5’-GACGTG-3’.
Similarly, trimers of the HREs from the EPO, ALD and PGK-1
genes were also synthesised (monomeric sequences for these are
given in Table 1b). All trimer oligonucleotides contained a unique
EcoRI restriction site (at the 5´ end of the sense strand for screening
purposes) and SacI and KpnI sites, allowing ligation into the
double-restricted pGL3 Promoter vector (Promega), which
contains the SV40 promoter (without the SV40 enhancer)
upstream of the firefly LUC gene.
Transient transfections and induction experiments
The Promega Dual LUC system was used to assess reporter gene
expression. In this system cells are co-transfected with a pRL plas-
mid (Renilla LUC driven by a full SV40 promoter), which is used
as an internal control. Normalizing the activity of the experimental
reporter to the activity of the internal control controls for experi-
mental variability and has been used to represent data concerning
HRE activity (Boast et al, 1999). Fold inductions were derived from
normalized firefly luciferase light units, by dividing the firefly/
Renilla luciferase ratio in the test condition (anoxia or hypoxia)
by the normoxic firefly/Renilla luciferase ratio (as described by
Boast et al, 1999). Cells were transfected with a 1 : 40 ratio of Renil-
la-LUC (control) and firefly LUC-expressing (i.e. test) plasmids,
using Fugene-6 (Boehringer Mannheim) according to the manufac-
E
xp
erim
en
tal
T
h
erap
eu
tics
Table 1 (A) Trimers of the wt and three mutant forms (M1-3) of the 14-bp SARE
5’-TAGCACGTACTCTTTAGCACGTACTCTTTAGCACGTACTC TT-3’ wt SARE
3’-ATCGTGCATGAGAAATCGTGCATGAGAAATCGTGCATGAGAA-5’
5’-TAGCACGTGCTCTTTAGCACGTGCTCTTTAGCACGTGCTCTT-3’ M1
3’-ATCGTGCACGAGAAATCGTGCACGAGAAATCGTGCACGAGAA-5’
5’-TAGTACGTACTCTTTAGTACGTACTCTTTAGTACGTACTCTT-3’ M2
3’-ATCATGCATGAGAAATCATGCATGAGAAATCATGCATGAGAA-5’
5’-TAGCACGTCCTCTTTAGCACGTCCTCTTTAGCACGTCCTC TT-3’ M3
3’-ATCGTGCAGGAGAAATCGTGCAGGAGAAATCGTGCAGGAGAA-5’
Mutated bases are underlined in M1-3
Table 1 (B) Comparison of the sequences of monomers of the wt SARE, the 14-bp
human ALD, 18 bp murine PGK-1 and the 26 bp human EPO HRE
5’-GGGCCCTACGTGCTGTCTCACACAGC-3’ hEPO
3’-CCCGGGATGCACGACAGAGTGTGTCG-5’
5’-TAGC ACGTACT C TT-3’ wt SARE
3’-ATCGTGCATGAGAA-5’
5’-C TTC ACGTGCGGGG-3’ ALD
3’-GAAGTGCACGCCCC-5’
5’-TAGCACGTGCT CTT-3’ M1
3’-ATCGTGCACGAGAA-5’
5’-TGTC AC GT CC TGCACGAC-3’ mPGK-1
3’-ACAGTGCAGGACGTGCTG-5’
5’-TAGCAC GT CC TC TT-3’ M3
3’-ATCGTGCAGGAGAA-5’
The HBS (5’-ACGTG-3’) is indicated in bold, and the putative ‘anoxia responsive’ motif (5’-ACGTA-
3’) in bold italics
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turer’s protocol. Transfected cells were plated into triplicate wells
for each condition in a 24-well plate (30 – 406103 cells per well),
and then exposed for 16 h to either normoxia (21% O2), or hypox-
ia (0.5, 1 or 4% O2, using multigas incubators set at either 4% O2/
5% CO2/91% N2, or 1% O2/5% CO2 /94% N2, or 0.5% O2/5%
CO2/94.5% N2) or anoxia (5% H2/5% CO2/90% N2 using an
anoxic glove-box incubator fitted with a palladium catalyst to
scavenge trace O2). Oxygen tensions in incubators were indepen-
dently confirmed using Analox oxygen meters. Cells were then
lysed and expression of both types of LUC assayed using the
Promega dual luciferase assay kit, and a Dynex MLX microtiter
plate luminometer.
Immunoblot assays
Nuclear extracts were made as described previously (Schreiber et al,
1989). Protein levels in these were determined using the Bio-Rad
protein assay kit. Antibodies used were: a mouse monoclonal anti-
body to HIF-1a (Signal Transduction Laboratories), a rabbit
polyclonal antibody to HIF-1b (Novus Biologicals), a sheep poly-
clonal antibody ATF-1 (from Biogenesis Ltd), and a monoclonal
antibody to human b-actin (Sigma; used to re-probe stripped blots
to control for loading differences in each assay). A mouse mono-
clonal antibody to human EPAS 1 (HIF-2a) was made in-house
(Wiesener et al, 1998). Antibodies were used at a final dilution
of 1 : 2000, except the EPAS 1 and b-actin antibodies which were
used at 1 : 1500 and 1 : 5000. 8% SDS/polyacrylamide gels were
used. Proteins were electroblotted onto Hybond-c Super nylon
membranes at 40 V for 3 h, and blocked in 5% skimmed milk/
0.5% Tween 20 in PBS overnight at 48C. Incubation with the
primary antibody was for 3 h at room temperature (RT). Incuba-
tion with the secondary HRP-conjugated antibody in 5% skimmed
milk powder in TBS (with 0.05% Tween 20) was then performed
for 1 h. Membranes were washed twice in 100 ml TBS/0.05%
Tween 20 and twice in 100 ml of TBS, and then incubated in
ECL immunoblotting detection reagents (Amersham Pharmacia
Biotech) and exposed to X-ray film.
Electrophoretic mobility shift and supershift assays
(EMSAs)
Oligonucleotides for EMSA were synthesised in-house and then
treated (each at a concentration of 100 mM ) in 10 mM Tris
pH 8.5, 50 mM NaCl at 958C for 5 min and allowed to anneal
by cooling to room temperature. Radiolabelling was carried out
by end-filling of the overhanging thymidines at each 5’ end using
Klenow polymerase (Life Technologies, Paisley, UK) to add 32P
labelled dATP ([a32P]dATP). Labelling reaction was carried out
in a total volume of 50 ml containing approximately 0.12 mM
probe, 16 reaction buffer (Life Technologies, Paisley, UK), 1 ml
of 10 mM dNTPs (excluding dATP), 2 ml [a32P]dATP (370 MBq
ml71) 1 ml Klenow polymerase (1 U ml71). The labelling reaction
mix was incubated for 15 min at 308C. The labelled probe was then
washed, removing unincorporated [a32P]dATP by using the
QIAquick Nucleotide Removal Kit (Qiagen, Sussex, UK) according
to the manufacturer’s protocol with a minor change which
included an additional wash of the labelled probe. The labelled
probe was then eluted in 50 ml of EB (Tris-Cl, pH 8.5) and the
purity was assessed by running 1 ml of the probe on a thin layer
chromatography (TLC) plate (Merck, Lutterworth, UK) using a
TLC separation buffer (1.2 M HCl and 0.8 M ammonium acetate),
and the purity of the labelled probe visualised by autoradiography.
In each binding reaction, 3 – 4 mg of nuclear extract was used. A
‘null SARE’ oligonucleotide (a mutated form of the SARE lacking a
5’-CGTG-3’ HIF-1 binding site consensus) was used as a competi-
tor at an excess of 100 – 200 fold (mM) over the radiolabelled SARE
or mutant SARE probes. The probe and competitor were pooled
and 0.87 ml used for each binding/competition assay (which was
carried out for 15 min at room temperature). Binding was carried
out in 10 mM Tris pH 8.0, 50 mM NaCl, 5 mM EDTA, 4% glycerol,
with 2.5 mM DTT (added just before use) in a total volume of
20 ml.
Sequences of the oligonucleotides used for the production of
probes and competitors were as follows (overhanging T’s and
unique EcoRI site shown in bold; monomers separated by a bar;
mutated bases underlined):
ARE trimer probe:
5’-TTTTAGCACGTACTCTT TAGCACGTACTCTT TAGCACG-
TACTCTTGAATTC-3’.
SARE null competitor trimer:
5’-TTTTAGCTATTACTCTT TAGCTATTACTCTT TAGCTAT-
TACTCTTGAATTC-3’.
For supershift assays, 1 – 2 mg antibody (to HIF-1a, HIF-1b,
EPAS 1, or ATF-1) was added to the binding reaction after
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Figure 1 Mean (+s.e.m.) fold induction (relative to normoxia; top pa-
nel), firefly LUC (middle panel) and Renilla LUC (bottom panel) detected
in MCF-7 cells following transfection with the pGL3 Promoter vector, or
this containing trimerised versions of the SARE, the human EPO HRE,
the human ALD HRE or the murine PGK-1 HRE. Cells were exposed to
0, 0.5, 1 or 21% O2 for 16 h. *P50.05 with respect to the same trimer
at 0.5% O2 (unpaired t-test). Pooled data from three experiments are
shown.
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15 min and incubated at room temperature for a further 30 min
before separation on a 3% non-denaturing polyacrylamide gel
run in 0.56 TBE buffer/300 v at 48C. The gel was then run for
1.5 h. Extracts were made as explained for immunoblots.
Statistics
An unpaired t-test was used to compare fold induction and/or
LUC values obtained for each trimer (i.e. at different O2 levels)
in Figures 1 – 4.
RESULTS
Comparison of the SARE with various HREs at different
oxygen tensions
No induction was seen for the pGL3 Promoter plasmid in hypoxia/
anoxia, but the SARE-LUC construct was highly inducible in both
hypoxia and anoxia. Normalised LUC induction values relative to
normoxia (21% O2) were approximately 170-fold in anoxia, 125-
fold in 0.5% O2, and 60-fold in 1% O2. The EPO HRE trimer gave
even higher fold inductions: 250-fold (anoxia), 215-fold (0.5% O2)
and 80-fold (1% O2). The patterns of induction of the SARE and
EPO were similar, being highest in anoxia and decreasing slightly
in 0.5%, but more markedly in 1% O2 (Figure 1). There was a
significant (P=0.003) difference between the fold induction of the
SARE (but not EPO HRE) in anoxia and 0.5% O2. Both trimers
however, showed a significant (P50.05) drop in 1% O2 relative
to anoxia. Due to its higher normoxic activity, the PGK-1 HRE
showed lower fold inductions than the SARE or EPO trimers,
particularly in anoxia, and showed no significant difference in fold
induction values between anoxia, 0.5% and 1% O2. The ALD HRE
trimer construct was the least inducible, giving similar values in
anoxia to those in 0.5 and 1% O2 (3 – 5 fold induction).
Although HRE activity has generally been represented as
normalised reporter gene expression (Boast et al, 1999), one has
to be cautious about resultant artefacts if the internal control
expression decreases in a particular experimental condition. For
example, the level of Renilla LUC produced under different O2
tensions contributes to the magnitude of the firefly luciferase/
Renilla LUC ratios and hence the fold induction data. Renilla
LUC values showed a marked progressive decrease as the oxygen
levels decreased, dropping by as much as 30 – 40% under anoxia
(Figure 1), an observation also reported by Dachs et al (2000). This
may reflect transcriptional/translational shutdown during oxygen
deprivation (Tinton et al, 1997). Although fold induction values
for the SARE and EPO were highest in anoxia, levels of firefly
LUC expression peaked at 0.5% O2. As Renilla LUC levels were
lower in anoxia, this gives the appearance of greater expression
from the SARE and EPO constructs in anoxia than hypoxia.
Although the levels of expression from the SARE- and EPO-driven
firefly LUC constructs were slightly reduced in anoxia relative to
0.5% O2, the decrease was not statistically significant. PGK-driven
firefly LUC expression dropped significantly (P=0.02) between
0.5% O2 and anoxia (Figure 1).
However, the trend in which the internal control responded to
the various O2 levels was similar between various experiments. In
all experiments, the Renilla luciferase light units dropped approxi-
mately 2.5-fold in anoxia compared to normoxia. Furthermore, the
Renilla luciferase light units in anoxia were not significantly
(P=0.2) different between different test groups, so the fold induc-
tion data suggest that the SARE was, indeed, further activated in
anoxia than in 0.5% O2.
Activity of the SARE, EPO and PGK-1 HREs in mild
(i.e. physiological) hypoxia
The above findings and previous reports of the rat VL30 being
silent in 5% O2 (Anderson et al, 1989) suggest that the SARE
and EPO HRE constructs may be more selective for low levels of
oxygen than the PGK-1 construct. We therefore examined the
responses of the SARE, EPO HRE and PGK-1-driven reporter
constructs to mild hypoxia (4% O2) (Figure 2). The PGK-1
HRE, but not the SARE or EPO HRE, was significantly
(P50.0001) induced in this oxygen tension.
Use of mutagenesis to investigate the function of the SARE
under anoxia and hypoxia
When trimerised, the SARE was induced 40-, 90- and 160-fold
(relative to normoxia) in MCF-7 cells (Figure 3i), and eight-, 15-
and 40-fold in T47D cells (Figure 4) in 1%, 0.5% and anoxia
respectively. No induction was seen for the pGL3 Promoter plas-
mid in hypoxia or anoxia. In anoxia, the SARE trimer produced
significantly (P=0.008) higher fold induction than in 0.5% O2
(Table 2). In contrast to these fold inductions, which were derived
from standardised mean relative light units (Firefly LUC values
standardised by expression of Renilla LUC), there was no signifi-
cant difference between the SARE-driven firefly LUC values in
0.5% and anoxia.
M1 resulted in markedly (410-fold) lower levels of induction
than the SARE (Figures 3a,b). M2 showed virtually no induction in
hypoxia or anoxia (Figure 3a). M3 responded with a similar trend
to the SARE in hypoxia and anoxia, albeit with a lower induction
(4four-fold induction difference), but significantly (P=0.006) higher
induction than M1 in anoxia and hypoxia (Figure 3a,b) (Table 2).
Analysis of transcription factor expression and binding
Low levels of HIF-1a and HIF-1b were detectable in normoxic
MCF-7 nuclear extracts. No HIF-2a (EPAS 1) was detected in
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Figure 2 Mean (+s.e.m) standardised LUC light units (ratio of firefly
LUC/Renilla LUC readings) detected in MCF-7 cells following transfection
with the pGL3 promoter vector or this containing trimerised versions of
the SARE, the human EPO HRE, the human ALD HRE, the murine PGK-
1 HRE. Cells were exposed to 4 or 21% O2 for 16 h. *P50.01 with re-
spect to same trimer at 21% O2 (unpaired t-test). Pooled data from three
experiments are shown.
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normoxia. Levels of all three of these proteins increased mark-
edly in hypoxia (1% and 0.5% O2) and anoxia (Figure 5). As
several members of the bZIP (basic/leucine zipper domain)
family of transcription factors such as ATF-1 have been impli-
cated in the regulation of HRE activity, and shown to bind to
the HBS in certain HREs (Kvietikova et al, 1995), we also
examined via immunoblot analysis the level of ATF-1 protein
in normoxia, hypoxia and anoxia. In addition, via electro-
phoretic mobility supershift assays, we also examined whether
ATF-1 binds the SARE. ATF-1 was present in normoxia,
elevated at 1% and 0.5% O2, but reduced in anoxia in
MCF-7 cells (Figure 5). Figure 6a shows that HIF-1 bound
to the radiolabelled SARE trimer at 0.5, 1 and 0% O2 in
EMSAs, and was supershifted by monoclonal antibodies to
HIF-1a and HIF-1b.
The HIF-1a monoclonal antibody also supershifted M1 (Figure
6b) and M3 probes (not shown). This is as expected since SARE,
M1 and M3 contain the HBS (5’-ACGTG-3’). Binding of undefined
constitutive factors was more extensive with the M1 than the
SARE, M 2 or M3 trimers (Figure 6b).
Antibodies to HIF-2a (EPAS 1), and ATF-1 did not supershift
the complex bound to the SARE trimer (Figure 7a). No HIF-1
binding was observed for the M2 probe, which lacks a HBS (Figure
7b).
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Figure 3 (a) Mean (+s.e.m.) fold induction (top panel), firefly LUC (middle panel) and Renilla LUC (bottom panel) detected in MCF-7 cells following
transfection with either the pGL3 Promoter vector or this containing trimerised versions of the wt SARE or mutant forms of this (M1 and M2; see Table 1).
Cells were exposed to 0, 0.5, 1 or 21% O2 for 16 h. *P50.05 with respect to the same trimer at 0.5% O2 (unpaired t-test). Pooled data from four experi-
ments are given. (b) Mean (+s.e.m.) fold induction (top panel), firefly LUC (middle panel) and Renilla LUC (bottom panel) in MCF-7 cells following transfec-
tion with either the pGL3 Promoter vector alone or this containing trimers of M1 or M3 following exposure to 0, 0.5, 1, or 21% O2 for 16 h. *P50.05 with
respect to the same trimer at 0.5% O2 (unpaired t-test). Pooled data from four experiments are given.
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Anoxic and hypoxic induction of the SARE in HIF-1a
knockout cells
In wild type CHO cells, the SARE was induced in both anoxia and
0.5% O2. However, no SARE induction was observed in anoxia or
0.5% O2 in HIF knockout CHO cells (Figure 8).
DISCUSSION
Here we show for the first time that the SARE is a potent HRE
with inductions (as an average of two sets of experiments,
presented as Figures 1 and 3) of 165-, 107-, and 50-fold in anoxia,
0.5, and 1% oxygen respectively in the human breast cancer cell
line MCF-7 in vitro. A similar pattern of SARE induction was seen
in another human breast cancer cell line, T47D. Thus, in contrast
to the other HRE constructs the SARE responded approximately
1.5-fold more in anoxia than in 0.5% O2 in MCF-7 cells. In order
to evaluate the potential role of the HBS (5’-ACGTG-3’), and the
‘HIF-1-like anoxia-responsive’ sequence 5’-ACGTA-3’ (Estes et al,
1995), in the anoxic inducibility of the SARE, we created single
point mutations of the SARE: M1, M2, and M3. In M1, the puta-
tive anoxia-responsive sequence (5’-ACGTA-3’) was ablated,
producing two identical HBS (with the sequence 5’-CACGTG-3’),
one on each strand, and changing the HIF site on the antisense
strand from the highly inducible 5’-TACGTG-3’ to the less induci-
ble 5’-CACGTG-3’ (Kimura et al, 2001). In accordance with their
findings, M1 responded poorly to hypoxia and anoxia.
In M2, the HBS on the antisense strand was ablated, creating
two putative ‘anoxia-responsive’ 5’-ACGTA-3’ sequences on oppos-
ing strands. This did not bind HIF-1 in our EMSAs or show
inducibility in hypoxia or anoxia, indicating that the sequence 5’-
ACGTA-3’ is not sufficient for hypoxic or anoxic induction of
the SARE. The Renilla luciferase (internal control) for M2 demon-
strated lower values than the Renilla luciferase plasmid for the
other constructs (Figure 3). This was probably due to the fact that
the experiments with M2 were performed on separate days –
further confirmed by the fact that the Renilla luciferase values
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Figure 4 Mean (+s.e.m.) fold induction in T47D cells following transfec-
tion with either the pGL3 Promoter vector alone or this containing a trimer
of the wtSARE following exposure to 0, 0.5, or 1% O2 for 16 h. *P50.05
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Figure 5 Immunoblot analysis of HIF-1a, HIF-1b, EPAS 1, and ATF-1 in
MCF-7 cells following exposure to 0, 0.5, 1, and 21% O2 (normoxia) for
16 h. Blots were stripped and re-probed for b-actin as a loading control;
no differences were observed (data not shown).
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Figure 6 (a) Electrophoretic mobility supershift assay showing binding of
HIF-1a and HIF-1b in MCF-7 extracts to the trimerised SARE probe follow-
ing exposure of cells for 16 hours to various O2 tensions. Bands appear in
1, 0.5 and 0% O2. These inducible complexes were supershifted in the pre-
sence of a monoclonal antibody to HIF-1a or a polyclonal antibody to HIF-
1b (C=binding of constitutive factors). (b) Electrophoretic mobility super-
shift assay showing the inducible HIF-1 band binding to the wt SARE or M1
trimers (the HIF-binding sequence of the latter being 5’-CACGTG-3’) in
nuclear extracts of MCF-7 cells exposed for 16 h to various O2 tensions.
Bands appear in 1, 0.5 and 0% O2 with both probes. These are super-
shifted by addition of a monoclonal antibody to HIF-1a. More extensive
binding of constitutive factors (‘C’) can be seen with M1 than with the
wt SARE probe.
Table 2 Effects of mutations immediately 5’ to the HBS, highlighted in
bold in M1 and M2 on the inducibility of the SARE in anoxia and 0.5% O2
Further
HIF-1 Fold induction in induction in
binding site Construct 0.5% hypoxia anoxia
5’-TACGTG-3’ SARE 689.3 61.7
(P=0.003)
Specific
HIF-1 sites
5’-GACGTG-3’ M3 621.0 62.4
(P=0.006)
Non-
5’-CACGTG-3’ M1 69.0 – specific
site
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for SARE and pGL3 transfections performed on the same day as
the M2 group also demonstrated lower values than the ones seen
in Figure 3. Despite these lower Renilla values, the SARE demon-
strated the usual pattern of induction as observed in Figures 3
and 4 (data not shown). Thus, the low Renilla values of M2 did
not account for its lack of inducibility.
To investigate the functionality of a SARE lacking the putative
‘anoxia-responsive’ 5’-ACGTA-3’ sequence, but with a more highly
inducible HBS than the 5’-CACGTG-3’ sequence present in M1,
M3 was constructed. In this, the 5’-ACGTA-3’ was mutated to
5’-ACGTc-3’, resulting in a change in the antisense strand HIF site
from the original 5’-TACGTG-3’ to 5’-GACGTG-3’. In agreement
with the findings of Kimura et al (2001), M3 demonstrated activity
intermediate between the SARE (5’-TACGTG-3’) and M1 (5’-
CACGTG-3’). Although firefly LUC expression in anoxia and
severe hypoxia (0.5% O2) was lower relative to normoxia for M3
than for the wild type SARE, this mutant was more selectively
inducible in anoxia and severe hypoxia (0.5% O2), relative to 1%
O2, than the SARE. The bases immediately 5’ to the HBS in the
SARE, M1 and M3 are identical to those in the EPO, ALD, and
PGK-1 HREs respectively. Trimers of these HREs demonstrated a
similar trend of induction to the SARE, M3 and M1 (i.e.
EPO4PGK4ALD; TACGTG4GACGTG4CACGTG; SARE4
M34M1). This accords well with functional studies of such
sequences in the promoters of hypoxia-responsive genes (Semenza
et al, 1996; Ebert et al, 1998), and also confirms the recent findings
of Kimura et al (2001) for the VEGF HRE, and thus may be a
common characteristic of HREs. In particular, the poor hypoxic
and anoxic inducibility of M1 compared to the SARE (from which
it differs only in the base immediately 5’ to the HBS), shows the
importance of this base in determining the inducibility of the
SARE at low O2 levels. The HBS in M1 is the same as the HBS
(5’-CACGTG-3’) present in the ALD gene. Interestingly, the ALD
HBS (5’-CACGTG-3’), which was poorly responsive in the context
of the SARE, has been shown previously to be non-responsive to
hypoxia (1% O2) in the context of the native ALD promoter
(Semenza et al, 1996). Thus, the data from the point mutation
analysis demonstrate that the function of the SARE in hypoxia
and anoxia is dependent on a highly inducible antisense HBS.
Interestingly, this HBS (including flanking base sequences, i.e. 5’-
TACGTGCT-3’) is identical to the one present in the hEPO HRE
sense strand, and both elements responded similarly to hypoxia
and anoxia.
A previous report by Ebert et al (1998) mentioned the impor-
tance of the 5’ flanking base of an HRE on the affinity of the
HBS for HIF-1. However our EMSA and induction data suggest
that it is not the binding affinity of these sites for HIF-1 that is
affected, but rather the ability of bound HIF-1 to activate tran-
scription at these different sites. M1, despite having two core
HBS (5’-CGTG-3’), and HIF-1 binding in EMSAs similar to that
of the SARE, is barely inducible, giving approximately 10-fold
lower levels of hypoxia-inducible transcriptional activation. This
suggests that either the mutation of the 5’-CGTA-3’ sequence to
5’-CGTg-3’, or the concomitant change from a 5’-TACGTG-3’ to
a 5’- cACGTG-3’ HBS on the antisense strand, while not affecting
the overall amount of HIF-1 binding, affects the ability of this
factor to activate transcription. The base 5’ to the HBS (5’-
ACGTG-3’) could be involved in the binding of an accessory
protein, alter the conformation and activity of HIF-1 bound to
the site, or selectively bind different post-translationally modified
forms of HIF-1. Furthermore, our EMSA results suggest that these
flanking bases may influence the specificity of the binding site for
HIF-1. The poorly inducible M1 (5’-cACGTG-3’) site showed
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Figure 7 (a) Electrophoretic mobility supershift assay showing HIF-1
binding to wt SARE in nuclear extracts of MCF-7 cells exposed for 16 h
to anoxia. The inducible HIF-1 band is super-shifted by addition of a mono-
clonal antibody to HIF-1a. Addition of the antibody to EPAS 1 (HIF-2a or
ATF-1 failed to supershift the constitutive factors (‘C’) or the inducible
band in anoxia. (b) Electrophoretic mobility supershift assay showing
HIF-1 binding to wt SARE in nuclear extracts of MCF-7 cells exposed for
16 h to anoxia. The inducible HIF-1 band is super-shifted by addition of
a monoclonal antibody to HIF-1a. M2 (which lacked the HBS) failed to bind
the inducible HIF-1 in the assay conditions used.
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Figure 8 Mean (+s.e.m.) standardised LUC light units (ratio of firefly
LUC/Renilla LUC readings) in either wild type (HIF-1 +/+) or HIF-1a
knockout (HIF-1 7/7) CHO cells (Wood et al, 1998) following transfec-
tion with a pGL3 Promoter plasmid expressing firefly LUC under control of
a trimer of the SARE, following exposure to 21% O2, 0.5% O2, or 0% O2
for 16 h. The SARE inducibility is lost in the HIF-1a knockout (HIF-1 7/7)
CHO cells. P=0.003 with respect to HIF-1 +/+ cells at 21% O2, or the
same oxygen tensions for HIF7/7 cells.
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greater binding to constitutive proteins than the SARE or M3,
which could explain why this mutant was so poorly inducible by
hypoxia and anoxia compared to the SARE and M3. Indeed, 5’-
CACGTG-3’ is a binding site for a number of other transcription
factors such as USF, c-Myc/Max and Rox/Max heterodimers, or
a homodimer of HIF-b (ARNT) (Meroni et al., 1997; Swanson
and Yang, 1999), some of which repress transcription upon bind-
ing. Similar levels of HIF-1a were seen at 1% O2, 0.5% O2, and
anoxia, and the EMSA indicated no major difference in HIF-1
binding to the SARE trimer between these oxygen levels. EPAS 1
and ATF-1 were also present in extracts of hypoxic and anoxic
MCF-7 cells, but our EPAS 1 and ATF-1 antibodies failed to
super-shift the protein complexes bound to the wt SARE probe.
The feasibility of using HRE-targeted gene therapy to treat
tumours systemically is likely to depend on: (1) high-level gene
expression in the severely hypoxic/anoxic sites in tumours; and
(2) no or low expression in normoxia and/or physiological hypox-
ia. We show that the SARE is a variant form of HRE that is highly
inducible in severe hypoxia and anoxia, with negligible activity in
mild physiological hypoxia (i.e. 4% O2) in human MCF-7 cells.
The differences between the inducibility of the SARE and its
mutant, M3, may be important for gene therapy. M3 demonstrated
higher fold induction in severe hypoxia/anoxia, relative to mild
hypoxia (1% O2) than the SARE. This measure of hypoxia specifi-
city is more relevant in terms of hypoxia-targeted gene therapy
than fold induction relative to 21% oxygen, which is super-physio-
logical. Interestingly, the absolute levels of LUC expression from
the SARE showed little difference between 0 – 1% O2, suggesting
that the level of expression is maintained at levels of oxygen below
1%, rather than being induced further by lower oxygen levels. It is
likely that M3 would be more suitable than the SARE for highly
targeted gene expression in severely hypoxic and anoxic sites, as
it would produce lower levels of expression in non-diseased, mildly
hypoxic tissues (i.e. containing 1% O2). However, M3 has a draw-
back; despite its greater specificity for severe hypoxia/anoxia, the
absolute levels of LUC expression were approximately six-fold
lower than those seen with the SARE in these conditions. This
could perhaps be compensated for by increasing transfection effi-
ciency or copy number, by combining with a stronger promoter
such as CMV, or by the production of constructs containing multi-
ple copies of a therapeutic gene driven by M3. The choice of the
HRE for systemic gene delivery would eventually also depend on
the type of vector used. An efficient tumour-targeting vector
(Ameri and Wagner, 2000; Kircheis et al, 2001) would widen the
choice of HREs by providing an extra level of targeting which
could by-pass certain tissues/organs that may contain low levels
of oxygen (Kircheis et al, 2001). Further work is now warranted
to demonstrate which of the HREs described here have utility in
such novel forms of gene therapy in vivo.
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